Fact.MR – A Market Research and Competitive Intelligence Provider: The global heart valve devices market is poised to grow at a CAGR of 13.4% from 2022 to 2032, expected to close at a valuation of US$ 37.5 Billion.
Over 40% of Heart Valve Devices Sales influenced by Transcatheter Valves until 2032, projects Fact.MR
“Technological progressions, increasing geriatric population, and an upsurge in prevalence of heart valve disorders (mitral regurgitation and aortic stenosis), and rise in minimally invasive techniques demand to bolster demand for prosthetic devices for heart,” comments a Fact.MR analyst.
Fact.MR – A Market Research and Competitive Intelligence Provider: The global heart valve devices market is poised to grow at a CAGR of 13.4% from 2022 to 2032, expected to close at a valuation of US$ 37.5 Billion. Sedentary lifestyles, physical inactivity and other habits such as smoking have induced the prevalence of cardiovascular diseases. Subsequently, the demand for minimally invasive procedures to address cardiac anomalies have increased substantially across the globe.
From 2015 to 2021, the market for heart valve devices grew at a CAGR of 13.1%, closing at a value of US$ 9.85 Billion. As of 2022, the industry is likely to reach US$ 11.16 Billion. Prospects heightened after the increasing awareness and soaring cases of cardiac problems like stroke, blood clots in developing countries.
Government policies lay emphasis on providing better healthcare infrastructure and better treatment for its citizens. Thereby, increment in the healthcare budget in several countries is boosting the demand for the transcatheter heart valve devices. Biological Heart Valve Devices increases the life expectancy and reduces the chances of heart attacks which will help in gaining new market grounds for prominent manufacturers.
Want A Detailed Understanding of Transcatheter Valve Replacement Market? Request for a Sample Here
https://www.factmr.com/connectus/sample?flag=S&rep_id=7388
Key Takeaways from the Market Study
- Global heart valve devices market to flourish 2.6x from 2022-2032
- Transcatheter heart valve devices to be a top-selling category, capturing more than 42% market and flourishing at a 17% CAGR until 2032
- By type, Biological heart valve devices is likely to expand at a CAGR of 8%
- U.S to emerge as the fastest-growing heart valve devices market, documenting a 13.7% CAGR
- China to be the 2nd most opportunistic market, expected to be valued at US$ 18.5 Billion in 2032
Competitive Landscape
The global market for heart valve devices is characterized by the presence of multiple vendors, aiming to offer extensive consulting and integration services to clients. Additionally, enterprises are seeking out, specialized service providers, offering solutions tailor-made to suit their business objectives. In addition, the vendors are likely to leverage up-gradation and product differentiation to gain an edge over other competitors in the market.
- In March 2022, Edwards Lifesciences Corporation received approval from the U.S. Food and Drug Administration (FDA) for the MITRIS RESILIA valve, a tissue valve replacement specifically designed for the heart’s mitral position.
- In January 2022, CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, made an announcement of renaming and rebranding itself to Artivion, Inc., effective immediately. Derived from the word’s “aorta”, “innovation”, and “vision”, the company’s new name and brand reflect its evolution to focus on providing innovative technologies to surgeons who treat patients with aortic disease.
To gain in-depth insights on Transcatheter Valve Replacement Market Report, request methodology at
https://www.factmr.com/connectus/sample?flag=RM&rep_id=7388
Segments Covered in Transcatheter Valve Replacement Industry Research
By Replacement Type:
- Transcatheter Aortic Valve Replacement (TAVR)
- Transcatheter Mitral Valve Repair (TMVR)
By Surgical Approach:
- Trans-femoral Approach
- Trans-apical Approach
- Trans-aortic Approach
By End User:
- Hospitals
- Ambulatory Surgical Centres
- Specialty Clinics
- Others
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
More Valuable Insights
Fact.MR, in its new offering, presents an unbiased analysis of the global heart valve devices market, presenting a historical analysis from 2015 to 2021 and forecast statistics for the period of 2022-2032.
The study reveals essential insights on the basis of type (mechanical heart valves, biological heart valve and transcatheter valves) and end-user (hospitals and ambulatory surgical centers) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).
Fact.MR’s Domain Knowledge in Healthcare
Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support - encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.
Check out more studies related to Healthcare Industry, conducted by Fact.MR:
Contrast Media Injectors Market Outlook (2022-2032) - With a Y-o-Y growth rate of 7.1%, the global contrast media injectors market is estimated at US$ 1.5 Billion in 2022, as against US$ 1.4 Billion in 2021. With the growing prevalence of cancer and rising investments, the market is expected to garner US$ 3.1 Billion in 2032, reflecting a CAGR of 7.4% from 2022 to 2032.
Fixed and Mobile C-Arms Market Outlook - The fixed and mobile c-arms market is predicted to grow at a steady CAGR of 4.3% during the projected period of 2022 to 2032. The fixed and mobile c-arms share is estimated to be worth more than US$ 4.8 Billion by 2032, increasing from US$ 3 Billion in 2021.
Collateral Ligament Stabilizer System Market Snapshot - The global collateral ligament stabilizer system market was valued at US$ 1.8 Billion in 2021, and is projected to register a Y-o-Y increase of 6.6% in 2022 to be valued at US$ 1.9 Billion.
Intrapartum Monitoring Devices Market Outlook (2022-2032) - The global intrapartum monitoring devices market was valued at US$ 2.2 Billion in 2021, and is projected to register a Y-o-Y increase of 4.5% in 2022 to be valued at US$ 2.3 Billion.
Europe Patient Positioning System Market Outlook (2022-2032) - The Europe patient positioning system market is currently valued at US$ 287.5 million and is projected to register 4.5% CAGR through 2032.
Mobile Imaging Services Market Outlook - The mobile imaging services market is predicted to grow at a steady CAGR of 3.9% during the projected period of 2022 to 2032. The mobile imaging services market share is estimated to be worth more than US$ 2.7 Billion by 2032.
U.S. Patient Positioning System Market Outlook (2022-2032) - Patient positioning system sales in the United States are estimated to cross a market valuation of US$ 324.8 million by the end of 2032. The U.S. patient positioning system market is forecasted to expand at 4.3% CAGR over the 2022-2032 assessment period.
Mixed Mode Chromatography Resin Market Outlook - The mixed mode chromatography resin market is predicted to grow at an impressive CAGR of 15.7% during the forecast period covering 2022 to 2032.
Idiopathic Thrombocytopenic Purpura Therapeutics Market Outlook (2022-2032)
The global idiopathic thrombocytopenic purpura therapeutics market was valued at US$ 587.0 Million in 2021, and is projected to be valued at US$ 620.5 Million in 2022. During the 2022-2032 period of assessment, demand is expected to rise at a 5.0% value CAGR.
Medical Nonwoven Disposables Market Outlook 2022 to 2032 - The medical nonwoven disposables market is predicted to grow at a moderate CAGR of 3.5% during the forecast period covering 2022 to 2032. The medical nonwoven disposables market share is estimated to reach a value of nearly US$ 28.9 Billion by 2032 expanding from US$ 19.7 Billion in 2021.
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Mahendra Singh
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
Email: sales@factmr.com
Tel: +1 (628) 251-158